Report cover image

Global Zinc Finger Nuclease Technology Market Growth (Status and Outlook) 2025-2031

Published Sep 05, 2025
Length 80 Pages
SKU # LPI20370902

Description

According to this study, the global Zinc Finger Nuclease Technology market size will reach US$ million by 2031.

Zinc-finger nucleases (ZFNs) are artificial restriction enzymes generated by fusing a zinc finger DNA-binding domain to a DNA-cleavage domain. Zinc finger domains can be engineered to target specific desired DNA sequences and this enables zinc-finger nucleases to target unique sequences within complex genomes. By taking advantage of endogenous DNA repair machinery, these reagents can be used to precisely alter the genomes of higher organisms. Alongside CRISPR/Cas9 and TALEN, ZFN is a prominent tool in the field of genome editing.

United States market for Zinc Finger Nuclease Technology is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Zinc Finger Nuclease Technology is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Zinc Finger Nuclease Technology is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Zinc Finger Nuclease Technology players cover Sigma-Aldrich, Sangamo Therapeutics, Labomics, Thermo Fisher Scientific, Gilead, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “Zinc Finger Nuclease Technology Industry Forecast” looks at past sales and reviews total world Zinc Finger Nuclease Technology sales in 2024, providing a comprehensive analysis by region and market sector of projected Zinc Finger Nuclease Technology sales for 2025 through 2031. With Zinc Finger Nuclease Technology sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Zinc Finger Nuclease Technology industry.

This Insight Report provides a comprehensive analysis of the global Zinc Finger Nuclease Technology landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Zinc Finger Nuclease Technology portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Zinc Finger Nuclease Technology market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Zinc Finger Nuclease Technology and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Zinc Finger Nuclease Technology.

This report presents a comprehensive overview, market shares, and growth opportunities of Zinc Finger Nuclease Technology market by product type, application, key players and key regions and countries.

Segmentation by Type:
Cell Line Engineering
Animal Genetic Engineering
Plant Genetic Engineering
Other

Segmentation by Application:
Biotechnology Companies
Pharmaceutical Companies
Hospital Laboratory and Diagnostic Laboratory
Academic and Research Institutes
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Sigma-Aldrich
Sangamo Therapeutics
Labomics
Thermo Fisher Scientific
Gilead

Please note: The report will take approximately 2 business days to prepare and deliver.

Table of Contents

80 Pages
*This is a tentative TOC and the final deliverable is subject to change.*
1 Scope of the Report
2 Executive Summary
3 Zinc Finger Nuclease Technology Market Size by Player
4 Zinc Finger Nuclease Technology by Region
5 Americas
6 APAC
7 Europe
8 Middle East & Africa
9 Market Drivers, Challenges and Trends
10 Global Zinc Finger Nuclease Technology Market Forecast
11 Key Players Analysis
12 Research Findings and Conclusion
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.